These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27860319)

  • 1. The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy.
    Cummings CA; Peters E; Lacroix L; Andre F; Lackner MR
    Clin Transl Sci; 2016 Dec; 9(6):283-292. PubMed ID: 27860319
    [No Abstract]   [Full Text] [Related]  

  • 2. Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
    Ziogas DE; Kyrochristos ID; Roukos DH
    Expert Rev Med Devices; 2018 Jan; 15(1):1-3. PubMed ID: 29284319
    [No Abstract]   [Full Text] [Related]  

  • 3. Precision oncology: East meets West.
    Subbiah V; Rodon J; Yap TA
    Int J Cancer; 2018 May; 142(9):1734-1737. PubMed ID: 29243227
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical utility of next-generation sequencing in precision oncology.
    Hux A; Lewis A; Sachwitz D; Gregory T
    JAAPA; 2019 Jan; 32(1):35-39. PubMed ID: 30589734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implementing next-generation sequencing for precision hematology/oncology].
    Maeda T
    Rinsho Ketsueki; 2018; 59(10):1924-1934. PubMed ID: 30305493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should next-generation sequencing tests be performed on all cancer patients?
    McKenzie AJ; H Dilks H; Jones SF; Burris H
    Expert Rev Mol Diagn; 2019 Feb; 19(2):89-93. PubMed ID: 30618301
    [No Abstract]   [Full Text] [Related]  

  • 7. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 8. [Precision oncology and molecular tumor boards].
    Mack E; Horak P; Fröhling S; Neubauer A
    Inn Med (Heidelb); 2024 May; 65(5):462-471. PubMed ID: 38652307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing access to next-generation sequencing in oncology for Brazil.
    Santos M; Coudry RA; Ferreira CG; Stefani S; Cunha IW; Zalis MG; Araujo LH
    Lancet Oncol; 2019 Jan; 20(1):20-23. PubMed ID: 30614460
    [No Abstract]   [Full Text] [Related]  

  • 10. The Architecture of a Precision Oncology Platform.
    Laganà A
    Adv Exp Med Biol; 2022; 1361():1-22. PubMed ID: 35230680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing in precision oncology: challenges and opportunities.
    Kruglyak KM; Lin E; Ong FS
    Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of precision medicine in modern molecular oncology.
    Wang Y; Zheng D
    Clin Genet; 2021 Sep; 100(3):248-257. PubMed ID: 33997970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding inequities in precision oncology diagnostics.
    Dutta R; Vallurupalli M; McVeigh Q; Huang FW; Rebbeck TR
    Nat Cancer; 2023 Jun; 4(6):787-794. PubMed ID: 37248397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
    Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
    Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
    [No Abstract]   [Full Text] [Related]  

  • 15. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.
    Nagarajan R; Bartley AN; Bridge JA; Jennings LJ; Kamel-Reid S; Kim A; Lazar AJ; Lindeman NI; Moncur J; Rai AJ; Routbort MJ; Vasalos P; Merker JD
    Arch Pathol Lab Med; 2017 Dec; 141(12):1679-1685. PubMed ID: 29028368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.
    Radovich M; Kiel PJ; Nance SM; Niland EE; Parsley ME; Ferguson ME; Jiang G; Ammakkanavar NR; Einhorn LH; Cheng L; Nassiri M; Davidson DD; Rushing DA; Loehrer PJ; Pili R; Hanna N; Callaghan JT; Skaar TC; Helft PR; Shahda S; O'Neil BH; Schneider BP
    Oncotarget; 2016 Aug; 7(35):56491-56500. PubMed ID: 27447854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing: hype and hope for development of personalized radiation therapy?
    Tinhofer I; Niehr F; Konschak R; Liebs S; Munz M; Stenzinger A; Weichert W; Keilholz U; Budach V
    Radiat Oncol; 2015 Aug; 10():183. PubMed ID: 26316159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision oncology: a clinical and patient perspective.
    Lassen UN; Makaroff LE; Stenzinger A; Italiano A; Vassal G; Garcia-Foncillas J; Avouac B
    Future Oncol; 2021 Oct; 17(30):3995-4009. PubMed ID: 34278817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Framework for the Next Generation of Precision Oncology Targets.
    Chen CT; Ford JM
    JAMA Oncol; 2022 Jul; 8(7):974-976. PubMed ID: 35587343
    [No Abstract]   [Full Text] [Related]  

  • 20. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.
    Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M
    Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.